No Data
No Data
AIDIGONG (00286) delayed the publication of its 2024 annual results.
AIDIGONG (00286) announced that the company will be unable to comply with the provisions of Listing Rule 13.49 (1) and (2) ...
AIDIGONG: INSIDE INFORMATION(1) DELAY IN PUBLICATION OF ANNUAL RESULTSANNOUNCEMENT AND DELAY IN DESPATCH OF ANNUALREPORT FOR THE YEAR ENDED 31 DECEMBER 2024;(2) FURTHER INFORMATION ON THE RESUMPTIONGUIDANCE; AND(3) CONTINUED SUSPENSION OF T...
Aidigong Maternal & Child Health Faces Trading Resumption Challenges
AIDIGONG (00286.HK) received the resumption guidance from the Stock Exchange.
On March 13, the company AIDIGONG (00286.HK) announced that on March 12, 2025, it received a letter from the stock exchange, which listed the guidelines for the resumption of trading of the company's shares as follows: (a) conduct an independent forensic investigation into the matters (including) and other related allegations, assess the impact on the company's Business Operation and financial status, publish the investigation results and take appropriate remedial measures; (b) demonstrate that there are no reasonable regulatory concerns regarding the integrity, capability, and/or character of any persons who have a significant impact on the group's management and/or the management and operation of the company, concerns that may affect investors.
Express News | The head of the National Health Commission, Lei Haichao, announced that parental subsidies will be issued this year, and the relevant operational plan is being drafted.
AIDIGONG (00286.HK) is facing a legal challenge from Zhu Yufei seeking resolution of the disagreement regarding the exercise of shareholder rights in Shenzhen AIDIGONG.
AIDIGONG (00286.HK) announced that it has received an arbitration request from Zhu Yufei against its wholly-owned subsidiary Guangdong Wanjia, seeking to resolve disputes regarding the exercise of shareholder rights in Shenzhen AIDIGONG. The company has received documents related to the arbitration, including a copy of a so-called delegation agreement. According to the agreement, Guangdong Wanjia is alleged to have irrevocably delegated all shareholder rights related to its 94.95% equity stake in Shenzhen AIDIGONG to Zhu Yufei. The company emphasizes that this delegation arrangement has not been notified, authorized, or approved by the Board of Directors and lacks commercial reasonableness. The company is currently consulting its legal advisors in mainland China regarding the arbitration matter.